Clinical trial
Functional Outcome After Transoral Robotic Surgery (TORS) vs Oncological Treatment for Oropharyngeal Squamous Cell Carcinoma
NCT03418909 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional Outcome After Transoral Robotic Surgery (TORS) vs Oncological Treatment for Oropharyngeal Squamous Cell Carcinoma
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2017
- Completion date
- June 30, 2024
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human papilloma virus, oropharynx cancer, pain, quality of life, saliva altered, swallowing disorder